Exploring the molecular targets and mechanisms of [10]-Gingerol for treating triple-negative breast cancer using bioinformatics approaches, molecular docking, and in vivo experiments

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive among breast cancer subtypes with the worst prognosis. Ginger is widely used in pharmaceuticals and as food. Its anticancer properties are known, but the mechanism is still unclear. [10]-Gingerol is one of the main phenolic comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ping, Zhou, Peijuan, Liang, Yuqi, Wu, Jiahua, Wu, Guosong, Xu, Rui, Dai, Yan, Guo, Qianqian, Lu, Hai, Chen, Qianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798581/
https://www.ncbi.nlm.nih.gov/pubmed/35116323
http://dx.doi.org/10.21037/tcr-21-1138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798581/
https://www.ncbi.nlm.nih.gov/pubmed/35116323
http://dx.doi.org/10.21037/tcr-21-1138

Ejemplares similares